CervoMed Inc.·4

Nov 17, 9:01 AM ET

Winton Matthew 4

4 · CervoMed Inc. · Filed Nov 17, 2025

Insider Transaction Report

Form 4
Period: 2025-11-14
Winton Matthew
Chief Commercial and Business
Transactions
  • Purchase

    Common Stock

    2025-11-14$7.57/sh+10,000$75,70010,000 total
Footnotes (2)
  • [F1]Shares purchased in open-market transactions.
  • [F2]The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.53 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4